Stem Cell Therapy for Early Alzheimer's Disease

Clinical trial NCT06775964 · RECRUITING

Trial details

NCT number: NCT06775964
Sponsor: Paul E Schulz
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cognitive Dysfunction

Start date: 2026-03-11
Primary completion: 2027-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.